{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:15Z","timestamp":1791860475129,"version":"4.3.4"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41575-018-0075-9","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T05:36:30Z","timestamp":1542605790000},"page":"121-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":571,"title":["Wnt\u2013\u03b2-catenin signalling in liver development, health and disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Maria J.","family":"Perugorria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Olaizola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibone","family":"Labiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Esparza-Baquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J. G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bujanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"75_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers, H. & Nusse, R. Wnt\/\u03b2-catenin signaling and disease. Cell 149, 1192\u20131205 (2012).","journal-title":"Cell"},{"key":"75_CR2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan, C. Y. & Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781\u2013810 (2004).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"75_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2017.05.015","volume":"428","author":"K Kretzschmar","year":"2017","unstructured":"Kretzschmar, K. & Clevers, H. Wnt\/\u03b2-catenin signaling in adult mammalian epithelial stem cells. Dev. Biol. 428, 273\u2013282 (2017).","journal-title":"Dev. Biol."},{"key":"75_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg1427","volume":"5","author":"RT Moon","year":"2004","unstructured":"Moon, R. T., Kohn, A. D., De Ferrari, G. V. & Kaykas, A. WNT and \u03b2-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691\u2013701 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"75_CR5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"75_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald, B. T., Tamai, K. & He, X. Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9\u201326 (2009).","journal-title":"Dev. Cell"},{"key":"75_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","volume":"16","author":"FH Brembeck","year":"2006","unstructured":"Brembeck, F. H., Rosario, M. & Birchmeier, W. Balancing cell adhesion and Wnt signaling, the key role of \u03b2-catenin. Curr. Opin. Genet. Dev. 16, 51\u201359 (2006).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"75_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbamem.2007.12.015","volume":"1778","author":"CM Niessen","year":"2008","unstructured":"Niessen, C. M. & Gottardi, C. J. Molecular components of the adherens junction. Biochim. Biophys. Acta 1778, 562\u2013571 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"75_CR9","doi-asserted-by":"crossref","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos, J. L. & Weis, W. I. The \u03b2-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 5, a007898 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"75_CR10","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1242\/dev.01318","volume":"131","author":"F Cong","year":"2004","unstructured":"Cong, F., Schweizer, L. & Varmus, H. Wnt signals across the plasma membrane to activate the \u03b2-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 131, 5103\u20135115 (2004).","journal-title":"Development"},{"key":"75_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature04185","volume":"438","author":"X Zeng","year":"2005","unstructured":"Zeng, X. et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438, 873\u2013877 (2005).","journal-title":"Nature"},{"key":"75_CR12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nature04170","volume":"438","author":"G Davidson","year":"2005","unstructured":"Davidson, G. et al. Casein kinase 1\u03b3 couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438, 867\u2013872 (2005).","journal-title":"Nature"},{"key":"75_CR13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nsmb1247","volume":"14","author":"T Schwarz-Romond","year":"2007","unstructured":"Schwarz-Romond, T. et al. The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat. Struct. Mol. Biol. 14, 484\u2013492 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cellsig.2009.11.021","volume":"22","author":"C Gao","year":"2010","unstructured":"Gao, C. & Chen, Y. G. Dishevelled: the hub of Wnt signaling. Cell. Signal. 22, 717\u2013727 (2010).","journal-title":"Cell Signal"},{"key":"75_CR15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cellsig.2007.10.031","volume":"20","author":"A Vlad","year":"2008","unstructured":"Vlad, A., Rohrs, S., Klein-Hitpass, L. & Muller, O. The first five years of the Wnt targetome. Cell. Signal. 20, 795\u2013802 (2008).","journal-title":"Cell Signal"},{"key":"75_CR16","doi-asserted-by":"crossref","first-page":"a007906","DOI":"10.1101\/cshperspect.a007906","volume":"4","author":"KM Cadigan","year":"2012","unstructured":"Cadigan, K. M. & Waterman, M. L. TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harb. Perspect. Biol. 4, a007906 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"75_CR17","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta, T., Hausmann, G. & Basler, K. The many faces and functions of \u03b2-catenin. EMBO J. 31, 2714\u20132736 (2012).","journal-title":"EMBO J."},{"key":"75_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ncb1534","volume":"9","author":"A Kaidi","year":"2007","unstructured":"Kaidi, A., Williams, A. C. & Paraskeva, C. Interaction between \u03b2-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9, 210\u2013217 (2007).","journal-title":"Nat. Cell Biol."},{"key":"75_CR19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.1109083","volume":"308","author":"MA Essers","year":"2005","unstructured":"Essers, M. A. et al. Functional interaction between \u03b2-catenin and FOXO in oxidative stress signaling. Science 308, 1181\u20131184 (2005).","journal-title":"Science"},{"key":"75_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/dvdy.22046","volume":"239","author":"JD Kormish","year":"2010","unstructured":"Kormish, J. D., Sinner, D. & Zorn, A. M. Interactions between SOX factors and Wnt\/\u03b2-catenin signaling in development and disease. Dev. Dyn. 239, 56\u201368 (2010).","journal-title":"Dev. Dyn."},{"key":"75_CR21","doi-asserted-by":"crossref","first-page":"a015081","DOI":"10.1101\/cshperspect.a015081","volume":"5","author":"CM Cruciat","year":"2013","unstructured":"Cruciat, C. M. & Niehrs, C. Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. 5, a015081 (2013).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"75_CR22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo, B. K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665\u2013669 (2012).","journal-title":"Nature"},{"key":"75_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao, H. X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195\u2013200 (2012).","journal-title":"Nature"},{"key":"75_CR24","doi-asserted-by":"crossref","first-page":"a007914","DOI":"10.1101\/cshperspect.a007914","volume":"4","author":"R Amerongen van","year":"2012","unstructured":"van Amerongen, R. Alternative Wnt pathways and receptors. Cold Spring Harb. Perspect. Biol. 4, a007914 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"75_CR25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-9525(02)02770-1","volume":"18","author":"M Mlodzik","year":"2002","unstructured":"Mlodzik, M. Planar cell polarization: do the same mechanisms regulate Drosophila tissue polarity and vertebrate gastrulation? Trends Genet. 18, 564\u2013571 (2002).","journal-title":"Trends Genet."},{"key":"75_CR26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1085259","volume":"300","author":"HY Wang","year":"2003","unstructured":"Wang, H. Y. & Malbon, C. C. Wnt signaling, Ca2+, and cyclic GMP: visualizing Frizzled functions. Science 300, 1529\u20131530 (2003).","journal-title":"Science"},{"key":"75_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature03126","volume":"433","author":"AE Chen","year":"2005","unstructured":"Chen, A. E., Ginty, D. D. & Fan, C. M. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433, 317\u2013322 (2005).","journal-title":"Nature"},{"key":"75_CR28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.21651","volume":"45","author":"MD Thompson","year":"2007","unstructured":"Thompson, M. D. & Monga, S. P. WNT\/\u03b2-catenin signaling in liver health and disease. Hepatology 45, 1298\u20131305 (2007).","journal-title":"Hepatology"},{"key":"75_CR29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"SP Monga","year":"2015","unstructured":"Monga, S. P. \u03b2-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology 148, 1294\u20131310 (2015).","journal-title":"Gastroenterology"},{"key":"75_CR30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.devcel.2016.08.011","volume":"38","author":"KM Loh","year":"2016","unstructured":"Loh, K. M., van Amerongen, R. & Nusse, R. Generating cellular diversity and spatial form: Wnt signaling and the evolution of multicellular animals. Dev. Cell 38, 643\u2013655 (2016).","journal-title":"Dev. Cell"},{"key":"75_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.devcel.2010.01.011","volume":"18","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb, K., Lemaigre, F. P. & Duncan, S. A. Organogenesis and development of the liver. Dev. Cell 18, 175\u2013189 (2010).","journal-title":"Dev. Cell"},{"key":"75_CR32","doi-asserted-by":"crossref","first-page":"R713","DOI":"10.1016\/S0960-9822(01)00417-1","volume":"11","author":"TP Yamaguchi","year":"2001","unstructured":"Yamaguchi, T. P. Heads or tails: Wnts and anterior-posterior patterning. Curr. Biol. 11, R713\u2013724 (2001).","journal-title":"Curr. Biol."},{"key":"75_CR33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/dvdy.22522","volume":"240","author":"AG Lade","year":"2011","unstructured":"Lade, A. G. & Monga, S. P. \u03b2-catenin signaling in hepatic development and progenitors: which way does the WNT blow? Dev. Dyn. 240, 486\u2013500 (2011).","journal-title":"Dev. Dyn."},{"key":"75_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4161\/org.4.2.5855","volume":"4","author":"K Nejak-Bowen","year":"2008","unstructured":"Nejak-Bowen, K. & Monga, S. P. Wnt\/\u03b2-catenin signaling in hepatic organogenesis. Organogenesis 4, 92\u201399 (2008).","journal-title":"Organogenesis"},{"key":"75_CR35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1534-5807(02)00321-0","volume":"3","author":"A Perea-Gomez","year":"2002","unstructured":"Perea-Gomez, A. et al. Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks. Dev. Cell 3, 745\u2013756 (2002).","journal-title":"Dev. Cell"},{"key":"75_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ydbio.2003.09.015","volume":"265","author":"Y Haramoto","year":"2004","unstructured":"Haramoto, Y. et al. Xenopus tropicalis nodal-related gene 3 regulates BMP signaling: an essential role for the pro-region. Dev. Biol. 265, 155\u2013168 (2004).","journal-title":"Dev. Biol."},{"key":"75_CR37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/dvdy.20574","volume":"234","author":"Y Onuma","year":"2005","unstructured":"Onuma, Y. et al. Xnr2 and Xnr5 unprocessed proteins inhibit Wnt signaling upstream of dishevelled. Dev. Dyn. 234, 900\u2013910 (2005).","journal-title":"Dev. Dyn."},{"key":"75_CR38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1126\/science.284.5422.1998","volume":"284","author":"J Jung","year":"1999","unstructured":"Jung, J., Zheng, M., Goldfarb, M. & Zaret, K. S. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284, 1998\u20132003 (1999).","journal-title":"Science"},{"key":"75_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ydbio.2004.01.019","volume":"268","author":"W Zhang","year":"2004","unstructured":"Zhang, W., Yatskievych, T. A., Baker, R. K. & Antin, P. B. Regulation of Hex gene expression and initial stages of avian hepatogenesis by Bmp and Fgf signaling. Dev. Biol. 268, 312\u2013326 (2004).","journal-title":"Dev. Biol."},{"key":"75_CR40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1567-133X(03)00091-7","volume":"3","author":"KR Finley","year":"2003","unstructured":"Finley, K. R., Tennessen, J. & Shawlot, W. The mouse secreted frizzled-related protein 5 gene is expressed in the anterior visceral endoderm and foregut endoderm during early post-implantation development. Gene Expr. Patterns 3, 681\u2013684 (2003).","journal-title":"Gene Expr Patterns"},{"key":"75_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mod.2005.10.001","volume":"123","author":"J Dessimoz","year":"2006","unstructured":"Dessimoz, J., Opoka, R., Kordich, J. J., Grapin-Botton, A. & Wells, J. M. FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo. Mech. Dev. 123, 42\u201355 (2006).","journal-title":"Mech. Dev."},{"key":"75_CR42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0959-437X(98)80006-3","volume":"8","author":"K Zaret","year":"1998","unstructured":"Zaret, K. Early liver differentiation: genetic potentiation and multilevel growth control. Curr. Opin. Genet. Dev. 8, 526\u2013531 (1998).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"75_CR43","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1242\/dev.127.11.2433","volume":"127","author":"JP Martinez Barbera","year":"2000","unstructured":"Martinez Barbera, J. P. et al. The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127, 2433\u20132445 (2000).","journal-title":"Development"},{"key":"75_CR44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ydbio.2005.11.006","volume":"290","author":"R Bort","year":"2006","unstructured":"Bort, R., Signore, M., Tremblay, K., Martinez Barbera, J. P. & Zaret, K. S. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev. Biol. 290, 44\u201356 (2006).","journal-title":"Dev. Biol."},{"key":"75_CR45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/gast.2003.50000","volume":"124","author":"SP Monga","year":"2003","unstructured":"Monga, S. P. et al. \u03b2-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124, 202\u2013216 (2003).","journal-title":"Gastroenterology"},{"key":"75_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ydbio.2003.10.010","volume":"266","author":"S Suksaweang","year":"2004","unstructured":"Suksaweang, S. et al. Morphogenesis of chicken liver: identification of localized growth zones and the role of \u03b2-catenin\/Wnt in size regulation. Dev. Biol. 266, 109\u2013122 (2004).","journal-title":"Dev. Biol."},{"key":"75_CR47","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.22225","volume":"47","author":"X Tan","year":"2008","unstructured":"Tan, X. et al. \u03b2-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 47, 1667\u20131679 (2008).","journal-title":"Hepatology"},{"key":"75_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/srep32888","volume":"6","author":"G Pettinato","year":"2016","unstructured":"Pettinato, G. et al. Scalable differentiation of human iPSCs in a multicellular spheroid-based 3D culture into hepatocyte-like cells through direct Wnt\/\u03b2-catenin pathway inhibition. Sci. Rep. 6, 32888 (2016).","journal-title":"Sci. Rep."},{"key":"75_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yexcr.2003.08.020","volume":"292","author":"SZ Hussain","year":"2004","unstructured":"Hussain, S. Z. et al. Wnt impacts growth and differentiation in ex vivo liver development. Exp. Cell Res. 292, 157\u2013169 (2004).","journal-title":"Exp. Cell Res."},{"key":"75_CR50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.21952","volume":"47","author":"T Decaens","year":"2008","unstructured":"Decaens, T. et al. Stabilization of \u03b2-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 47, 247\u2013258 (2008).","journal-title":"Hepatology"},{"key":"75_CR51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2016.12.003","volume":"66","author":"C Gerard","year":"2017","unstructured":"Gerard, C., Tys, J. & Lemaigre, F. P. Gene regulatory networks in differentiation and direct reprogramming of hepatic cells. Semin. Cell Dev. Biol. 66, 43\u201350 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"75_CR52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ydbio.2008.04.021","volume":"319","author":"K Matsumoto","year":"2008","unstructured":"Matsumoto, K., Miki, R., Nakayama, M., Tatsumi, N. & Yokouchi, Y. Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium. Dev. Biol. 319, 234\u2013247 (2008).","journal-title":"Dev. Biol."},{"key":"75_CR53","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0002-9440(10)63779-0","volume":"164","author":"SS Sekhon","year":"2004","unstructured":"Sekhon, S. S., Tan, X., Micsenyi, A., Bowen, W. C. & Monga, S. P. Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors. Am. J. Pathol. 164, 2229\u20132240 (2004).","journal-title":"Am. J. Pathol."},{"key":"75_CR54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.diff.2016.02.001","volume":"91","author":"S Cordi","year":"2016","unstructured":"Cordi, S. et al. Role of \u03b2-catenin in development of bile ducts. Differentiation 91, 42\u201349 (2016).","journal-title":"Differentiation"},{"key":"75_CR55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2017.02.017","volume":"67","author":"M Merino-Azpitarte","year":"2017","unstructured":"Merino-Azpitarte, M. et al. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. J. Hepatol. 67, 72\u201383 (2017).","journal-title":"J. Hepatol."},{"key":"75_CR56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1152\/physrev.1989.69.3.708","volume":"69","author":"K Jungermann","year":"1989","unstructured":"Jungermann, K. & Katz, N. Functional specialization of different hepatocyte populations. Physiol. Rev. 69, 708\u2013764 (1989).","journal-title":"Physiol. Rev."},{"key":"75_CR57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","volume":"10","author":"S Benhamouche","year":"2006","unstructured":"Benhamouche, S. et al. Apc tumor suppressor gene is the \u201czonation-keeper\u201d of mouse liver. Dev. Cell 10, 759\u2013770 (2006).","journal-title":"Dev. Cell"},{"key":"75_CR58","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.27082","volume":"60","author":"J Yang","year":"2014","unstructured":"Yang, J. et al. \u03b2-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation! Hepatology 60, 964\u2013976 (2014).","journal-title":"Hepatology"},{"key":"75_CR59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang, B., Zhao, L., Fish, M., Logan, C. Y. & Nusse, R. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature 524, 180\u2013185 (2015).","journal-title":"Nature"},{"key":"75_CR60","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.celrep.2015.10.049","volume":"13","author":"AS Rocha","year":"2015","unstructured":"Rocha, A. S. et al. The angiocrine factor rspondin3 is a key determinant of liver zonation. Cell Rep. 13, 1757\u20131764 (2015).","journal-title":"Cell Rep."},{"key":"75_CR61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ncb3337","volume":"18","author":"L Planas-Paz","year":"2016","unstructured":"Planas-Paz, L. et al. The RSPO-LGR4\/5-ZNRF3\/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18, 467\u2013479 (2016).","journal-title":"Nat. Cell Biol."},{"key":"75_CR62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2010.12.010","volume":"21","author":"KN Nejak-Bowen","year":"2011","unstructured":"Nejak-Bowen, K. N. & Monga, S. P. \u03b2-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin. Cancer Biol. 21, 44\u201358 (2011).","journal-title":"Semin. Cancer Biol."},{"key":"75_CR63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/hep.21973","volume":"47","author":"U Apte","year":"2008","unstructured":"Apte, U. et al. Wnt\/\u03b2-catenin signaling mediates oval cell response in rodents. Hepatology 47, 288\u2013295 (2008).","journal-title":"Hepatology"},{"key":"75_CR64","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.2353\/ajpath.2010.080486","volume":"176","author":"JM Williams","year":"2010","unstructured":"Williams, J. M. et al. The role of the Wnt family of secreted proteins in rat oval \u201cstem\u201d cell-based liver regeneration: Wnt1 drives differentiation. Am. J. Pathol. 176, 2732\u20132742 (2010).","journal-title":"Am. J. Pathol."},{"key":"75_CR65","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/aps.2014.150","volume":"36","author":"XK Ji","year":"2015","unstructured":"Ji, X. K. et al. GSK-3\u03b2 suppresses the proliferation of rat hepatic oval cells through modulating Wnt\/\u03b2-catenin signaling pathway. Acta Pharmacol. Sin. 36, 334\u2013342 (2015).","journal-title":"Acta Pharmacol. Sin."},{"key":"75_CR66","doi-asserted-by":"crossref","first-page":"20395","DOI":"10.18632\/oncotarget.7954","volume":"7","author":"JY Kim","year":"2016","unstructured":"Kim, J. Y. et al. CWP232228 targets liver cancer stem cells through Wnt\/\u03b2-catenin signaling: a novel therapeutic approach for liver cancer treatment. Oncotarget 7, 20395\u201320409 (2016).","journal-title":"Oncotarget"},{"key":"75_CR67","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/jhep.2001.23786","volume":"33","author":"SP Monga","year":"2001","unstructured":"Monga, S. P., Pediaditakis, P., Mule, K., Stolz, D. B. & Michalopoulos, G. K. Changes in WNT\/\u03b2-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33, 1098\u20131109 (2001).","journal-title":"Hepatology"},{"key":"75_CR68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2005.02.019","volume":"43","author":"D Sodhi","year":"2005","unstructured":"Sodhi, D. et al. Morpholino oligonucleotide-triggered \u03b2-catenin knockdown compromises normal liver regeneration. J. Hepatol. 43, 132\u2013141 (2005).","journal-title":"J. Hepatol."},{"key":"75_CR69","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2006.08.042","volume":"131","author":"X Tan","year":"2006","unstructured":"Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K. & Monga, S. P. Conditional deletion of \u03b2-catenin reveals its role in liver growth and regeneration. Gastroenterology 131, 1561\u20131572 (2006).","journal-title":"Gastroenterology"},{"key":"75_CR70","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch, A. et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the \u03b2-catenin gene. Cancer Res. 59, 269\u2013273 (1999).","journal-title":"Cancer Res."},{"key":"75_CR71","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777\u2013D783 (2017).","journal-title":"Nucleic Acids Res."},{"key":"75_CR72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.onc.1203356","volume":"19","author":"Y Wei","year":"2000","unstructured":"Wei, Y. et al. Activation of \u03b2-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19, 498\u2013504 (2000).","journal-title":"Oncogene"},{"key":"75_CR73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"27","author":"D Lopez-Terrada","year":"2014","unstructured":"Lopez-Terrada, D. et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod. Pathol. 27, 472\u2013491 (2014).","journal-title":"Mod. Pathol."},{"key":"75_CR74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","volume":"17","author":"D Bell","year":"2017","unstructured":"Bell, D., Ranganathan, S., Tao, J. & Monga, S. P. Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-catenin perspective. Gene Expr. 17, 141\u2013154 (2017).","journal-title":"Gene Expr"},{"key":"75_CR75","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","volume":"40","author":"AM Adesina","year":"2009","unstructured":"Adesina, A. M. et al. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum. Pathol. 40, 843\u2013853 (2009).","journal-title":"Hum. Pathol."},{"key":"75_CR76","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14, 471\u2013484 (2008).","journal-title":"Cancer Cell"},{"key":"75_CR77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2009.07.012","volume":"43","author":"C Armengol","year":"2011","unstructured":"Armengol, C., Cairo, S., Fabre, M. & Buendia, M. A. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int. J. Biochem. Cell Biol. 43, 265\u2013270 (2011).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"75_CR78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nm1606","volume":"13","author":"A Goga","year":"2007","unstructured":"Goga, A., Yang, D., Tward, A. D., Morgan, D. O. & Bishop, J. M. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med. 13, 820\u2013827 (2007).","journal-title":"Nat. Med."},{"key":"75_CR79","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1158\/1535-7163.MCT-15-0206","volume":"14","author":"M Ilmer","year":"2015","unstructured":"Ilmer, M. et al. Targeting the neurokinin-1 receptor compromises canonical Wnt signaling in hepatoblastoma. Mol. Cancer Ther. 14, 2712\u20132721 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"75_CR80","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2741\/e393","volume":"4","author":"S Cairo","year":"2012","unstructured":"Cairo, S., Armengol, C. & Buendia, M. A. Activation of Wnt and Myc signaling in hepatoblastoma. Front. Biosci. 4, 480\u2013486 (2012).","journal-title":"Front. Biosci."},{"key":"75_CR81","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada, D. et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum. Pathol. 40, 783\u2013794 (2009).","journal-title":"Hum. Pathol."},{"key":"75_CR82","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao, J. et al. Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147, 690\u2013701 (2014).","journal-title":"Gastroenterology"},{"key":"75_CR83","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner, A., Reig, M. & Bruix, J. Hepatocellular carcinoma. Lancet 391, 1301\u20131314 (2018).","journal-title":"Lancet"},{"key":"75_CR84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J Taipale","year":"2001","unstructured":"Taipale, J. & Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349\u2013354 (2001).","journal-title":"Nature"},{"key":"75_CR85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/02841860600602946","volume":"45","author":"FC Kelleher","year":"2006","unstructured":"Kelleher, F. C., Fennelly, D. & Rafferty, M. Common critical pathways in embryogenesis and cancer. Acta Oncol. 45, 375\u2013388 (2006).","journal-title":"Acta Oncol."},{"key":"75_CR86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","volume":"13","author":"JO Russell","year":"2017","unstructured":"Russell, J. O. & Monga, S. S. Wnt\/\u03b2-catenin signaling in liver development, homeostasis, and pathobiology. Annu. Rev. Pathol. 13, 351\u2013378 (2017).","journal-title":"Annu. Rev. Pathol."},{"key":"75_CR87","first-page":"1441","volume":"23","author":"A Ihara","year":"1996","unstructured":"Ihara, A., Koizumi, H., Hashizume, R. & Uchikoshi, T. Expression of epithelial cadherin and \u03b1- and \u03b2-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23, 1441\u20131447 (1996).","journal-title":"Hepatology"},{"key":"75_CR88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/73448","volume":"24","author":"S Satoh","year":"2000","unstructured":"Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24, 245\u2013250 (2000).","journal-title":"Nat. Genet."},{"key":"75_CR89","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.4254\/wjh.v7.i26.2631","volume":"7","author":"J Waisberg","year":"2015","unstructured":"Waisberg, J. & Saba, G. T. Wnt\u2212\/\u2212\u03b2-catenin pathway signaling in human hepatocellular carcinoma. World J. Hepatol. 7, 2631\u20132635 (2015).","journal-title":"World J. Hepatol."},{"key":"75_CR90","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","volume":"64","author":"S Rebouissou","year":"2016","unstructured":"Rebouissou, S. et al. Genotype-phenotype correlation of CTNNB1 mutations reveals different ss-catenin activity associated with liver tumor progression. Hepatology 64, 2047\u20132061 (2016).","journal-title":"Hepatology"},{"key":"75_CR91","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.3748\/wjg.v21.i20.6317","volume":"21","author":"SL Ding","year":"2015","unstructured":"Ding, S. L. et al. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. World J. Gastroenterol. 21, 6317\u20136328 (2015).","journal-title":"World J. Gastroenterol."},{"key":"75_CR92","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygeno.2013.04.001","volume":"102","author":"ML Tornesello","year":"2013","unstructured":"Tornesello, M. L. et al. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 102, 74\u201383 (2013).","journal-title":"Genomics"},{"key":"75_CR93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505\u2013511 (2015).","journal-title":"Nat. Genet."},{"key":"75_CR94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","volume":"25","author":"CC Lau","year":"2014","unstructured":"Lau, C. C. et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 25, 335\u2013349 (2014).","journal-title":"Cancer Cell"},{"key":"75_CR95","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4161\/epi.5.8.13104","volume":"5","author":"Y Jia","year":"2010","unstructured":"Jia, Y. et al. SOX17 antagonizes WNT\/\u03b2-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 5, 743\u2013749 (2010).","journal-title":"Epigenetics"},{"key":"75_CR96","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/hep.25933","volume":"56","author":"CM Tsao","year":"2012","unstructured":"Tsao, C. M. et al. SOX1 functions as a tumor suppressor by antagonizing the WNT\/\u03b2-catenin signaling pathway in hepatocellular carcinoma. Hepatology 56, 2277\u20132287 (2012).","journal-title":"Hepatology"},{"key":"75_CR97","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1038\/onc.2013.225","volume":"33","author":"H Quan","year":"2014","unstructured":"Quan, H. et al. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Oncogene 33, 2826\u20132835 (2014).","journal-title":"Oncogene"},{"key":"75_CR98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.stem.2015.03.003","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 16, 413\u2013425 (2015).","journal-title":"Cell Stem Cell"},{"key":"75_CR99","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/gutjnl-2016-312278","volume":"66","author":"P Carotenuto","year":"2017","unstructured":"Carotenuto, P. et al. Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. Gut 66, 1268\u20131277 (2017).","journal-title":"Gut"},{"key":"75_CR100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4161\/epi.4.5.9371","volume":"4","author":"Y Ying","year":"2009","unstructured":"Ying, Y. & Tao, Q. Epigenetic disruption of the WNT\/\u03b2-catenin signaling pathway in human cancers. Epigenetics 4, 307\u2013312 (2009).","journal-title":"Epigenetics"},{"key":"75_CR101","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.1011098108","volume":"108","author":"C Braconi","year":"2011","unstructured":"Braconi, C. et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 108, 786\u2013791 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"75_CR102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.neo.2016.10.004","volume":"18","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Blocking Wnt secretion reduces growth of hepatocellular carcinoma cell lines mostly independent of \u03b2-catenin signaling. Neoplasia 18, 711\u2013723 (2016).","journal-title":"Neoplasia"},{"key":"75_CR103","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/onc.2017.207","volume":"36","author":"A Debebe","year":"2017","unstructured":"Debebe, A. et al. Wnt\/\u03b2-catenin activation and macrophage induction during liver cancer development following steatosis. Oncogene 36, 6020\u20136029 (2017).","journal-title":"Oncogene"},{"key":"75_CR104","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep.27558","volume":"61","author":"X Zhi","year":"2015","unstructured":"Zhi, X. et al. \u03b2II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology 61, 598\u2013612 (2015).","journal-title":"Hepatology"},{"key":"75_CR105","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","volume":"152","author":"KKY Lai","year":"2017","unstructured":"Lai, K. K. Y. et al. Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a Wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6. Gastroenterology 152, 1477\u20131491 (2017).","journal-title":"Gastroenterology"},{"key":"75_CR106","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2010.06.033","volume":"54","author":"SB Nambotin","year":"2011","unstructured":"Nambotin, S. B. et al. Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. J. Hepatol. 54, 288\u2013299 (2011).","journal-title":"J. Hepatol."},{"key":"75_CR107","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","volume":"59","author":"F Pez","year":"2013","unstructured":"Pez, F. et al. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J. Hepatol. 59, 1107\u20131117 (2013).","journal-title":"J. Hepatol."},{"key":"75_CR108","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/hep.28821","volume":"64","author":"S Chai","year":"2016","unstructured":"Chai, S. et al. Octamer 4\/microRNA-1246 signaling axis drives Wnt\/\u03b2-catenin activation in liver cancer stem cells. Hepatology 64, 2062\u20132076 (2016).","journal-title":"Hepatology"},{"key":"75_CR109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3892\/or.2013.2831","volume":"31","author":"W Gu","year":"2014","unstructured":"Gu, W., Li, X. & Wang, J. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT\/TCF-4 pathway. Oncol. Rep. 31, 397\u2013404 (2014).","journal-title":"Oncol. Rep."},{"key":"75_CR110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2016.01.005","volume":"64","author":"C Qu","year":"2016","unstructured":"Qu, C. et al. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT\/\u03b2-catenin activation. J. Hepatol. 64, 1076\u20131089 (2016).","journal-title":"J. Hepatol."},{"key":"75_CR111","first-page":"1971","volume":"62","author":"N Harada","year":"2002","unstructured":"Harada, N. et al. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of \u03b2-catenin. Cancer Res. 62, 1971\u20131977 (2002).","journal-title":"Cancer Res."},{"key":"75_CR112","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.23538","volume":"51","author":"KN Nejak-Bowen","year":"2010","unstructured":"Nejak-Bowen, K. N. et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant \u03b2-catenin. Hepatology 51, 1603\u20131613 (2010).","journal-title":"Hepatology"},{"key":"75_CR113","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","volume":"74","author":"S Mokkapati","year":"2014","unstructured":"Mokkapati, S. et al. \u03b2-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res. 74, 4515\u20134525 (2014).","journal-title":"Cancer Res."},{"key":"75_CR114","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/hep.28601","volume":"64","author":"J Tao","year":"2016","unstructured":"Tao, J. et al. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant \u03b2-catenin. Hepatology 64, 1587\u20131605 (2016).","journal-title":"Hepatology"},{"key":"75_CR115","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.28975","volume":"65","author":"J Tao","year":"2017","unstructured":"Tao, J. et al. Targeting \u03b2-catenin in hepatocellular cancers induced by coexpression of mutant \u03b2-catenin and K-Ras in mice. Hepatology 65, 1581\u20131599 (2017).","journal-title":"Hepatology"},{"key":"75_CR116","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1073\/pnas.0404761101","volume":"101","author":"S Colnot","year":"2004","unstructured":"Colnot, S. et al. Liver-targeted disruption of Apc in mice activates \u03b2-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 101, 17216\u201317221 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"75_CR117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4161\/cc.5.6.2550","volume":"5","author":"SH Lam","year":"2006","unstructured":"Lam, S. H. & Gong, Z. Modeling liver cancer using zebrafish: a comparative oncogenomics approach. Cell Cycle 5, 573\u2013577 (2006).","journal-title":"Cell Cycle"},{"key":"75_CR118","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature04888","volume":"442","author":"EA Ober","year":"2006","unstructured":"Ober, E. A., Verkade, H., Field, H. A. & Stainier, D. Y. Mesodermal Wnt2b signalling positively regulates liver specification. Nature 442, 688\u2013691 (2006).","journal-title":"Nature"},{"key":"75_CR119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005305","volume":"11","author":"KJ Evason","year":"2015","unstructured":"Evason, K. J. et al. Identification of chemical inhibitors of \u03b2-catenin-driven liver tumorigenesis in zebrafish. PLOS Genet. 11, e1005305 (2015).","journal-title":"PLOS Genet."},{"key":"75_CR120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales, J. M. et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75_CR121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi, S., Khan, S. A., Hallemeier, C. L., Kelley, R. K. & Gores, G. J. Cholangiocarcinoma \u2014 evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 15, 95\u2013111 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"75_CR122","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362, 1273\u20131281 (2010).","journal-title":"N. Engl. J. Med."},{"key":"75_CR123","first-page":"973","volume":"27","author":"N Tokumoto","year":"2005","unstructured":"Tokumoto, N. et al. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int. J. Oncol. 27, 973\u2013980 (2005).","journal-title":"Int. J. Oncol."},{"key":"75_CR124","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.7314\/APJCP.2014.15.23.10463","volume":"15","author":"S Yothaisong","year":"2014","unstructured":"Yothaisong, S. et al. Opisthorchis viverrini infection activates the PI3K\/ AKT\/PTEN and Wnt\/\u03b2-catenin signaling pathways in a Cholangiocarcinogenesis model. Asian Pac. J. Cancer Prev. 15, 10463\u201310468 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"75_CR125","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3892\/or.2013.2560","volume":"30","author":"KS Zhang","year":"2013","unstructured":"Zhang, K. S., Zhou, Q., Wang, Y. F. & Liang, L. J. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells. Oncol. Rep. 30, 1430\u20131438 (2013).","journal-title":"Oncol. Rep."},{"key":"75_CR126","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880409","volume":"14","author":"K Sugimachi","year":"2001","unstructured":"Sugimachi, K. et al. Altered expression of \u03b2-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod. Pathol. 14, 900\u2013905 (2001).","journal-title":"Mod. Pathol."},{"key":"75_CR127","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","volume":"59","author":"B Goeppert","year":"2014","unstructured":"Goeppert, B. et al. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway. Hepatology 59, 544\u2013554 (2014).","journal-title":"Hepatology"},{"key":"75_CR128","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/15592294.2016.1227899","volume":"11","author":"B Goeppert","year":"2016","unstructured":"Goeppert, B. et al. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma. Epigenetics 11, 780\u2013790 (2016).","journal-title":"Epigenetics"},{"key":"75_CR129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopha.2017.07.025","volume":"94","author":"F Zhang","year":"2017","unstructured":"Zhang, F. et al. Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt\/\u03b2-catenin-signaling pathway. Biomed. Pharmacother. 94, 55\u201362 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"75_CR130","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1007\/s13277-014-1698-2","volume":"35","author":"W Loilome","year":"2014","unstructured":"Loilome, W. et al. Activated macrophages promote Wnt\/\u03b2-catenin signaling in cholangiocarcinoma cells. Tumour Biol. 35, 5357\u20135367 (2014).","journal-title":"Tumour Biol."},{"key":"75_CR131","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI76452","volume":"125","author":"L Boulter","year":"2015","unstructured":"Boulter, L. et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J. Clin. Invest. 125, 1269\u20131285 (2015).","journal-title":"J. Clin. Invest."},{"key":"75_CR132","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/cas.12223","volume":"104","author":"DY Shen","year":"2013","unstructured":"Shen, D. Y., Zhang, W., Zeng, X. & Liu, C. Q. Inhibition of Wnt\/\u03b2-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma. Cancer Sci. 104, 1303\u20131308 (2013).","journal-title":"Cancer Sci."},{"key":"75_CR133","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/MCB.00384-13","volume":"33","author":"GL Huang","year":"2013","unstructured":"Huang, G. L. et al. Oncogenic activity of retinoic acid receptor gamma is exhibited through activation of the Akt\/NF-kappaB and Wnt\/\u03b2-catenin pathways in cholangiocarcinoma. Mol. Cell. Biol. 33, 3416\u20133425 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"75_CR134","doi-asserted-by":"crossref","first-page":"18905","DOI":"10.18632\/oncotarget.4305","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Oncotarget 6, 18905\u201318920 (2015).","journal-title":"Oncotarget"},{"key":"75_CR135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman, S. L. Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol. 7, 425\u2013436 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75_CR136","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125\u2013172 (2008).","journal-title":"Physiol. Rev."},{"key":"75_CR137","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLOS ONE 8, e84407 (2013).","journal-title":"PLOS ONE"},{"key":"75_CR138","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","volume":"9","author":"WS Ge","year":"2014","unstructured":"Ge, W. S. et al. \u03b2-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/\u03b2-catenin signaling inhibits hepatic stellate cell activation. Mol. Med. Rep. 9, 2145\u20132151 (2014).","journal-title":"Mol. Med. Rep."},{"key":"75_CR139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2006.03.016","volume":"45","author":"F Jiang","year":"2006","unstructured":"Jiang, F., Parsons, C. J. & Stefanovic, B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J. Hepatol. 45, 401\u2013409 (2006).","journal-title":"J. Hepatol."},{"key":"75_CR140","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3748\/wjg.v18.i15.1745","volume":"18","author":"WJ Xiong","year":"2012","unstructured":"Xiong, W. J. et al. Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J. Gastroenterol. 18, 1745\u20131752 (2012).","journal-title":"World J. Gastroenterol."},{"key":"75_CR141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142794","volume":"10","author":"L Corbett","year":"2015","unstructured":"Corbett, L., Mann, J. & Mann, D. A. Non-canonical Wnt predominates in activated rat hepatic stellate cells, influencing HSC survival and paracrine stimulation of Kupffer cells. PLOS ONE 10, e0142794 (2015).","journal-title":"PLOS ONE"},{"key":"75_CR142","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.febslet.2007.05.050","volume":"581","author":"SJ Myung","year":"2007","unstructured":"Myung, S. J. et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett. 581, 2954\u20132958 (2007).","journal-title":"FEBS Lett."},{"key":"75_CR143","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","volume":"294","author":"JH Cheng","year":"2008","unstructured":"Cheng, J. H. et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G39\u2013G49 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"75_CR144","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/liv.12757","volume":"35","author":"N Chatani","year":"2015","unstructured":"Chatani, N. et al. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int. 35, 2017\u20132026 (2015).","journal-title":"Liver Int."},{"key":"75_CR145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156111","volume":"11","author":"SM Kweon","year":"2016","unstructured":"Kweon, S. M., Chi, F., Higashiyama, R., Lai, K. & Tsukamoto, H. Wnt pathway stabilizes MeCP2 protein to repress PPAR-\u03b3 in activation of hepatic stellate cells. PLOS ONE 11, e0156111 (2016).","journal-title":"PLOS ONE"},{"key":"75_CR146","volume":"7","author":"Y Tokunaga","year":"2017","unstructured":"Tokunaga, Y. et al. Selective inhibitor of Wnt\/\u03b2-catenin\/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model. Sci. Rep. 7, 325 (2017).","journal-title":"Sci. Rep."},{"key":"75_CR147","doi-asserted-by":"crossref","first-page":"30463","DOI":"10.1074\/jbc.M110.156703","volume":"285","author":"NL Zhu","year":"2010","unstructured":"Zhu, N. L., Wang, J. & Tsukamoto, H. The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor \u03b3 repression in hepatic stellate cells. J. Biol. Chem. 285, 30463\u201330471 (2010).","journal-title":"J. Biol. Chem."},{"key":"75_CR148","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2006.04.012","volume":"131","author":"EL Haughton","year":"2006","unstructured":"Haughton, E. L. et al. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 131, 194\u2013209 (2006).","journal-title":"Gastroenterology"},{"key":"75_CR149","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.2015.58","volume":"95","author":"F Yu","year":"2015","unstructured":"Yu, F., Guo, Y., Chen, B., Dong, P. & Zheng, J. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 95, 781\u2013789 (2015).","journal-title":"Lab Invest."},{"key":"75_CR150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18632\/oncotarget.6447","volume":"7","author":"F Yu","year":"2016","unstructured":"Yu, F. et al. MicroRNA-17-5p-activated Wnt\/\u03b2-catenin pathway contributes to the progression of liver fibrosis. Oncotarget 7, 81\u201393 (2016).","journal-title":"Oncotarget"},{"key":"75_CR151","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molimm.2016.05.018","volume":"75","author":"DD Zhou","year":"2016","unstructured":"Zhou, D. D. et al. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt\/\u03b2-catenin pathway. Mol. Immunol. 75, 151\u2013160 (2016).","journal-title":"Mol. Immunol."},{"key":"75_CR152","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1159\/000452509","volume":"39","author":"F Yu","year":"2016","unstructured":"Yu, F., Fan, X., Chen, B., Dong, P. & Zheng, J. Activation of hepatic stellate cells is inhibited by microRNA-378a-3p via Wnt10a. Cell Physiol. Biochem. 39, 2409\u20132420 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"75_CR153","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13069-015-0036-7","volume":"8","author":"KM Irvine","year":"2015","unstructured":"Irvine, K. M. et al. Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogen. Tissue Repair 8, 19 (2015).","journal-title":"Fibrogen. Tissue Repair"},{"key":"75_CR154","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhep.2017.03.012","volume":"67","author":"ME Preziosi","year":"2017","unstructured":"Preziosi, M. E. et al. Mice lacking liver-specific \u03b2-catenin develop steatohepatitis and fibrosis after iron overload. J. Hepatol. 67, 360\u2013369 (2017).","journal-title":"J. Hepatol."},{"key":"75_CR155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2015.02.030","volume":"63","author":"CK Huang","year":"2015","unstructured":"Huang, C. K. et al. Restoration of Wnt\/\u03b2-catenin signaling attenuates alcoholic liver disease progression in a rat model. J. Hepatol. 63, 191\u2013198 (2015).","journal-title":"J. Hepatol."},{"key":"75_CR156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","volume":"72","author":"I Reccia","year":"2017","unstructured":"Reccia, I. et al. Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism 72, 94\u2013108 (2017).","journal-title":"Metabolism"},{"key":"75_CR157","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(16)30011-5","volume":"1","author":"VW Wong","year":"2016","unstructured":"Wong, V. W. et al. Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. Lancet Gastroenterol. Hepatol. 1, 56\u201367 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"75_CR158","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24766","volume":"55","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. \u03b2-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology 55, 931\u2013940 (2012).","journal-title":"Hepatology"},{"key":"75_CR159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cmet.2013.11.023","volume":"19","author":"GW Go","year":"2014","unstructured":"Go, G. W. et al. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metab. 19, 209\u2013220 (2014).","journal-title":"Cell Metab."},{"key":"75_CR160","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.15-271171","volume":"29","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. Faseb J. 29, 3436\u20133445 (2015).","journal-title":"Faseb J."},{"key":"75_CR161","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M111.286724","volume":"287","author":"W Liu","year":"2012","unstructured":"Liu, W. et al. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J. Biol. Chem. 287, 7213\u20137223 (2012).","journal-title":"J. Biol. Chem."},{"key":"75_CR162","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.numecd.2012.10.010","volume":"23","author":"V Nobili","year":"2013","unstructured":"Nobili, V. et al. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. Nutr. Metab. Cardiovasc. Dis. 23, 1066\u20131070 (2013).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"75_CR163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157246","volume":"11","author":"G Carpino","year":"2016","unstructured":"Carpino, G. et al. Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway. PLOS ONE 11, e0157246 (2016).","journal-title":"PLOS ONE"},{"key":"75_CR164","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen, K., Jaeschke, H. & Copple, B. L. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am. J. Pathol. 178, 175\u2013186 (2011).","journal-title":"Am. J. Pathol."},{"key":"75_CR165","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23801","volume":"52","author":"TH Yeh","year":"2010","unstructured":"Yeh, T. H. et al. Liver-specific \u03b2-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis. Hepatology 52, 1410\u20131419 (2010).","journal-title":"Hepatology"},{"key":"75_CR166","doi-asserted-by":"crossref","first-page":"86985","DOI":"10.18632\/oncotarget.13521","volume":"7","author":"UJ Lemberger","year":"2016","unstructured":"Lemberger, U. J. et al. Hepatocyte specific expression of an oncogenic variant of \u03b2-catenin results in cholestatic liver disease. Oncotarget 7, 86985\u201386998 (2016).","journal-title":"Oncotarget"},{"issue":"Suppl. 1","key":"75_CR167","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","volume":"37","author":"E Vries de","year":"2017","unstructured":"de Vries, E. & Beuers, U. Management of cholestatic disease in 2017. Liver Int. 37 (Suppl. 1), 123\u2013129 (2017).","journal-title":"Liver Int."},{"key":"75_CR168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/jaut.2001.0522","volume":"17","author":"A Tanaka","year":"2001","unstructured":"Tanaka, A. et al. Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis. J. Autoimmun 17, 89\u201398 (2001).","journal-title":"J. Autoimmun"},{"key":"75_CR169","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.49.4.565","volume":"49","author":"NA Shackel","year":"2001","unstructured":"Shackel, N. A., McGuinness, P. H., Abbott, C. A., Gorrell, M. D. & McCaughan, G. W. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49, 565\u2013576 (2001).","journal-title":"Gut"},{"key":"75_CR170","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2353\/ajpath.2010.100173","volume":"177","author":"MD Thompson","year":"2010","unstructured":"Thompson, M. D., Awuah, P., Singh, S. & Monga, S. P. Disparate cellular basis of improved liver repair in \u03b2-catenin-overexpressing mice after long-term exposure to 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Am. J. Pathol. 177, 1812\u20131822 (2010).","journal-title":"Am. J. Pathol."},{"key":"75_CR171","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.28774","volume":"64","author":"H Okabe","year":"2016","unstructured":"Okabe, H. et al. Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice. Hepatology 64, 1652\u20131666 (2016).","journal-title":"Hepatology"},{"key":"75_CR172","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/labinvest.2009.103","volume":"89","author":"SD Sackett","year":"2009","unstructured":"Sackett, S. D. et al. Foxl1 promotes liver repair following cholestatic injury in mice. Lab Invest. 89, 1387\u20131396 (2009).","journal-title":"Lab Invest."},{"key":"75_CR173","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrgastro.2014.155","volume":"11","author":"MJ Perugorria","year":"2014","unstructured":"Perugorria, M. J. et al. Polycystic liver diseases: advanced insights into the molecular mechanisms. Nat. Rev. Gastroenterol. Hepatol. 11, 750\u2013761 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75_CR174","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrgastro.2017.69","volume":"14","author":"MJ Perugorria","year":"2017","unstructured":"Perugorria, M. J. & Banales, J. M. Genetics: Novel causative genes for polycystic liver disease. Nat. Rev. Gastroenterol. Hepatol. 14, 391\u2013392 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75_CR175","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.29577","volume":"67","author":"AI Masyuk","year":"2017","unstructured":"Masyuk, A. I. et al. Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target. Hepatology 67, 1088\u20131108 (2017).","journal-title":"Hepatology"},{"key":"75_CR176","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1073\/pnas.1309438111","volume":"111","author":"WR Cnossen","year":"2014","unstructured":"Cnossen, W. R. et al. Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis. Proc. Natl Acad. Sci. USA 111, 5343\u20135348 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"75_CR177","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1093\/hmg\/ddx308","volume":"26","author":"ES Wills","year":"2017","unstructured":"Wills, E. S. et al. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling. Hum. Mol. Genet. 26, 4190\u20134202 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"75_CR178","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/hep.26554","volume":"58","author":"C Spirli","year":"2013","unstructured":"Spirli, C. et al. Protein kinase A-dependent pSer(675) -\u03b2-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis. Hepatology 58, 1713\u20131723 (2013).","journal-title":"Hepatology"},{"key":"75_CR179","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.28382","volume":"63","author":"L Locatelli","year":"2016","unstructured":"Locatelli, L. et al. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology 63, 965\u2013982 (2016).","journal-title":"Hepatology"},{"key":"75_CR180","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/hep.29652","volume":"67","author":"E Kaffe","year":"2017","unstructured":"Kaffe, E. et al. \u03b2-catenin and IL-1\u03b2 dependent CXCL10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 67, 1903\u20131919 (2017).","journal-title":"Hepatology"},{"key":"75_CR181","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2017","unstructured":"Krishnamurthy, N. & Kurzrock, R. Targeting the Wnt\/\u03b2-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat. Rev. 62, 50\u201360 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"75_CR182","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02069145 (2014)."},{"key":"75_CR183","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02675946 (2016)."},{"key":"75_CR184","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02375880 (2015)."},{"key":"75_CR185","doi-asserted-by":"crossref","first-page":"70378","DOI":"10.18632\/oncotarget.11859","volume":"7","author":"XD Shi","year":"2016","unstructured":"Shi, X. D. et al. Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma. Oncotarget 7, 70378\u201370387 (2016).","journal-title":"Oncotarget"},{"key":"75_CR186","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jhep.2008.11.020","volume":"50","author":"B Yu","year":"2009","unstructured":"Yu, B. et al. Elevated expression of DKK1 is associated with cytoplasmic\/nuclear \u03b2-catenin accumulation and poor prognosis in hepatocellular carcinomas. J. Hepatol. 50, 948\u2013957 (2009).","journal-title":"J. Hepatol."},{"key":"75_CR187","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1111\/bph.13894","volume":"174","author":"MH Kagey","year":"2017","unstructured":"Kagey, M. H. & He, X. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. Br. J. Pharmacol. 174, 4637\u20134650 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"75_CR188","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02195440 (2014)."},{"key":"75_CR189","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1158\/1535-7163.MCT-16-0309","volume":"15","author":"S Ganesh","year":"2016","unstructured":"Ganesh, S. et al. Direct pharmacological inhibition of \u03b2-catenin by RNA interference in tumors of diverse origin. Mol. Cancer Ther. 15, 2143\u20132154 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"75_CR190","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1517\/14728222.2014.906580","volume":"18","author":"A Sebio","year":"2014","unstructured":"Sebio, A., Kahn, M. & Lenz, H. J. The potential of targeting Wnt\/\u03b2-catenin in colon cancer. Expert Opin. Ther. Targets 18, 611\u2013615 (2014).","journal-title":"Expert Opin. Ther. Targets"},{"key":"75_CR191","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","volume":"154","author":"HG Palmer","year":"2001","unstructured":"Palmer, H. G. et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of \u03b2-catenin signaling. J. Cell Biol. 154, 369\u2013387 (2001).","journal-title":"J. Cell Biol."},{"key":"75_CR192","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/stem.1706","volume":"32","author":"K Osei-Sarfo","year":"2014","unstructured":"Osei-Sarfo, K. & Gudas, L. J. Retinoic acid suppresses the canonical Wnt signaling pathway in embryonic stem cells and activates the noncanonical Wnt signaling pathway. Stem Cells 32, 2061\u20132071 (2014).","journal-title":"Stem Cells"},{"key":"75_CR193","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Vitamin D deficiency promotes liver tumor growth in transforming growth factor-\u03b2\/Smad3-deficient mice through Wnt and Toll-like Receptor 7 pathway modulation. Sci. Rep. 6, 30217 (2016).","journal-title":"Sci. Rep."},{"key":"75_CR194","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.18632\/oncotarget.2000","volume":"5","author":"KC Chiang","year":"2014","unstructured":"Chiang, K. C. et al. Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a chemical-induced animal model. Oncotarget 5, 3849\u20133861 (2014).","journal-title":"Oncotarget"},{"key":"75_CR195","volume":"8","author":"H Xia","year":"2017","unstructured":"Xia, H. & Hui, K. M. Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer. Cell Death Dis. 8, e3112 (2017).","journal-title":"Cell Death Dis."},{"key":"75_CR196","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.28529","volume":"64","author":"J Choi","year":"2016","unstructured":"Choi, J. et al. Aspirin use and the risk of cholangiocarcinoma. Hepatology 64, 785\u2013796 (2016).","journal-title":"Hepatology"},{"key":"75_CR197","first-page":"2085","volume":"60","author":"MA Rahman","year":"2000","unstructured":"Rahman, M. A. et al. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res. 60, 2085\u20132089 (2000).","journal-title":"Cancer Res."},{"key":"75_CR198","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.jss.2008.10.006","volume":"157","author":"SC Wentz","year":"2009","unstructured":"Wentz, S. C. et al. Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo. J. Surg. Res. 157, e87\u201395 (2009).","journal-title":"J. Surg. Res."},{"key":"75_CR199","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02013154 (2013)."},{"key":"75_CR200","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02655952 (2016)."},{"key":"75_CR201","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02020291 (2013)."},{"key":"75_CR202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn, M. Can we safely target the WNT pathway? Nat. Rev. Drug Discov. 13, 513\u2013532 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75_CR203","first-page":"2344","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang, X. & Hao, J. Development of anticancer agents targeting the Wnt\/\u03b2-catenin signaling. Am. J. Cancer Res. 5, 2344\u20132360 (2015).","journal-title":"Am. J. Cancer Res."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0075-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T10:39:22Z","timestamp":1720780762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-018-0075-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":203,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1038\/s41575-018-0075-9","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"19 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}